

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Total Revenue | 18.33 | 21.09 | 3.38 |
| Total Expenses | 18.14 | 21.04 | 3.37 |
| Profit Before Tax | 0.19 | 0.05 | 0.01 |
| Profit After Tax | 0.06 | 0.04 | 0.01 |
| Operating Profit After Depreciation | 0.32 | 0.09 | 0.02 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Fixed Assets | 0.55 | 0.34 | 0.15 |
| Total Non Current Assets | 0.62 | 0.43 | 0.23 |
| Total Current Assets | 17.03 | 14.93 | 4.78 |
| Total Assets | 17.66 | 15.36 | 5.01 |
| Total Shareholder's Fund | 4.20 | 4.14 | 4.11 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Net Cash From Operating Activities | 0.12 | -0.77 | -0.68 |
| Net Cash Used In Investing Activities | -0.42 | -0.28 | -0.01 |
| Net Cash Used In Financing Activities | 0.48 | 0.86 | 0.34 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 18.32 | 6.38 | 3.38 | 4.21 | 3.06 |
| Total Expenses | 18.07 | 6.32 | 3.37 | 4.15 | 3.02 |
| Profit Before Tax | 0.26 | 0.06 | 0.01 | 0.07 | 0.04 |
| Profit After Tax | 0.13 | 0.05 | 0.01 | 0.05 | 0.03 |
| Operating Profit After Depreciation | 0.39 | 0.08 | 0.02 | 0.07 | 0.05 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 0.46 | 0.24 | 0.15 | 0.17 | 0.16 |
| Total Non Current Assets | 0.59 | 0.37 | 0.23 | 0.27 | 0.23 |
| Total Current Assets | 12.42 | 9.13 | 4.78 | 4.36 | 2.02 |
| Total Assets | 13.01 | 9.50 | 5.01 | 4.62 | 2.25 |
| Total Shareholder's Fund | 4.29 | 4.16 | 4.11 | 4.10 | 1.30 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -0.12 | -2.99 | -0.68 | -1.90 | -0.45 |
| Net Cash Used In Investing Activities | 2.11 | -0.18 | -0.01 | -0.05 | -0.10 |
| Net Cash Used In Financing Activities | 0.73 | 0.43 | 0.34 | 2.47 | 0.45 |
No data available
| Particulars (in ₹ Cr.) | 2021-09 | 2021-06 |
|---|---|---|
| Total Revenue | - | 1.13 |
| Total Expenses | - | 1.10 |
| Profit Before Tax | - | 0.02 |
| Profit After Tax | -0.07 | 0.01 |
| Operating Profit after Depreciation | - | 0.03 |
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
No data available
On 23 May 2026
22 May 2026, 10:48 am
On 13 November 2025
11 Nov 2025, 03:26 pm
On 22 September 2025
03 Sep 2025, 09:51 am

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.